929 results found

2015年年末，国家发展和改革委员会（"发改委"）对八家滚装货物国际海运企业达成并实施价格垄断协议的行为做出了严厉的处罚，合计罚款人民०

On August 9, 2024, the State Administration for Market Regulation (SAMR) released the Anti-Monopoly Guidelines for the Pharmaceutical Sector (Draft for Public Comment) (hereinafter referred to as the Pharmaceutical Anti-Monopoly Guidelines or the Guidelines) to solicit opinions from the public.

There was substantial progress of the merger control regime and antitrust administrative and cartel investigations.

2022年6月24日，经第十三届全国人大常委会第三十五次会议审议通过的《中华人民共和国反垄断法（修正案）》（"《反垄断法》"）正式公布并于2022年

自欧盟《外国补贴条例》（"Foreign Subsidy Regulation"或"FSR"）生效以来，欧委会在两年多的执法实践中已经审查了大量案件，从2025年底至今尤为活跃。

The European Commission has released its first enforcement review of the Foreign Subsidies Regulation (FSR), declaring the framework 'fit for purpose' while proposing only targeted procedural adjustments.

In today's rapidly growing global economy, for businesses seeking to stand out in fierce market competition, intangible assets or intellectual property rights...

2023年3月24日，国家市场监督管理总局公布《禁止滥用市场支配地位行为规定》《禁止垄断协议规定》《经营者集中审查规定》《制止滥用行政权Ó

应当承认，算法的运用和个性化设置经常能够产生诸多积极效果，提高商业运行效率。

Administrative Case on Distinctiveness of a Phrase Mark: Company A vs. China National Intellectual Property Administration (CNIPA), Administrative Dispute over Refusal of Trademark Application...

China's Supreme People's Court released ten landmark intellectual property cases from 2025, covering trademark distinctiveness, patent infringement in chip technology, trade secret theft, unfair competition through employee poaching and data scraping, and criminal prosecution of counterfeiters. These decisions establish important precedents for balancing innovation incentives with public interests while demonstrating China's commitment to strengthening IP protection in the digital economy.

Almost three years have passed since China formally established its security review system with regard to mergers and acquisitions of domestic enter¬prises by foreign investors ("Security Review System").

2025年1月23日，国务院反垄断反不正当竞争委员会正式发布了《关于药品领域的反垄断指南》（"《指南》正式稿"）。从2024年8月9日发布征求意见稿到2025&

On January 2, 2020, China's national antitrust authority, the State Administration for Market Regulation (SAMR), released a draft of amendments (Draft Amendment) to the Anti-Monopoly Law...

The Anti-Monopoly Judicial Interpretation is expected to play an important role in the monopoly civil dispute cases.

"出海"对中国企业而言，已经逐渐从选择题演变成了发展的必经之路。

上述规定并未将劳动者的亲属纳入竞业限制人员的范围，对于应当承担竞业限制义务的劳动者，也未限制其亲属到与劳动者原雇主生产、经营